Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Lanes

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Pharmacoepidemiology and Drug Safety|February 8, 2023
Validation to correct for outcome misclassification biasStephan Lanes, Daniel C Beachler
American Journal of Respiratory and Critical Care Medicine|February 25, 2003
Ipratropium and lung health studyStephan Lanes, Wolfgang Golisch, Jaromir Mikl
Clinical Trials (London, England)|February 20, 2008
Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimationSander Greenland, Stephan Lanes, Michele Jara
BMJ Open|May 24, 2012
A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPDMichele Jara, Charles Wentworth, Stephan Lanes
The American Journal of Medicine|July 6, 2004
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicamGurkirpal Singh, Stephan Lanes, George Triadafilopoulos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2013
Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systemsCatherine J Mercaldi, Stephan Lanes, Jason Bradt
Chest|December 15, 2006
Pooled clinical trial analysis of tiotropium safetySteven Kesten, Michele Jara, Charles Wentworth, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2004
The reporting odds ratio and its advantages over the proportional reporting ratioKenneth J Rothman, Stephan Lanes, Susan T Sacks
JAMA Network Open|March 5, 2026
Package Insert Warnings and Liver Function Tests for CDK4/6 Inhibitors for Breast CancerDaniel C Beachler, Vincent Lo Re, Stephan Lanes
The Journal of Infection|October 31, 2020
Prior presumed coronavirus infection reduces COVID-19 risk: A cohort studyDvir Aran, Daniel C Beachler, Stephan Lanes, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Pharmacoepidemiology and Drug Safety|February 8, 2023
Validation to correct for outcome misclassification biasStephan Lanes, Daniel C Beachler
American Journal of Respiratory and Critical Care Medicine|February 25, 2003
Ipratropium and lung health studyStephan Lanes, Wolfgang Golisch, Jaromir Mikl
Clinical Trials (London, England)|February 20, 2008
Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimationSander Greenland, Stephan Lanes, Michele Jara
BMJ Open|May 24, 2012
A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPDMichele Jara, Charles Wentworth, Stephan Lanes
The American Journal of Medicine|July 6, 2004
Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicamGurkirpal Singh, Stephan Lanes, George Triadafilopoulos
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 21, 2013
Comparative risk of bloodstream infection in hospitalized patients receiving intravenous medication by open, point-of-care, or closed delivery systemsCatherine J Mercaldi, Stephan Lanes, Jason Bradt
Chest|December 15, 2006
Pooled clinical trial analysis of tiotropium safetySteven Kesten, Michele Jara, Charles Wentworth, et al.
Pharmacoepidemiology and Drug Safety|August 19, 2004
The reporting odds ratio and its advantages over the proportional reporting ratioKenneth J Rothman, Stephan Lanes, Susan T Sacks
JAMA Network Open|March 5, 2026
Package Insert Warnings and Liver Function Tests for CDK4/6 Inhibitors for Breast CancerDaniel C Beachler, Vincent Lo Re, Stephan Lanes
The Journal of Infection|October 31, 2020
Prior presumed coronavirus infection reduces COVID-19 risk: A cohort studyDvir Aran, Daniel C Beachler, Stephan Lanes, et al.
Pageof 6